Connect Biopharma Holdings Ltd ADR (NASDAQ: CNTB) kicked off on Friday, up 32.17% from the previous trading day, before settling in for the closing price of $1.15. Over the past 52 weeks, CNTB has traded in a range of $0.51-$1.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 7.77% over the last five years. While this was happening, its average annual earnings per share was recorded -208.02%. With a float of $53.25 million, this company’s outstanding shares have now reached $55.35 million.
The firm has a total of 62 workers. Let’s measure their productivity. In terms of profitability, gross margin is 97.47%, operating margin of -67.61%, and the pretax margin is -58.96%.
Connect Biopharma Holdings Ltd ADR (CNTB) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The most recent insider transaction that took place on Jun 11 ’25, was worth 32,218.
Connect Biopharma Holdings Ltd ADR (CNTB) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -208.02% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -24.12% during the next five years compared to 7.77% growth over the previous five years of trading.
Connect Biopharma Holdings Ltd ADR (NASDAQ: CNTB) Trading Performance Indicators
Take a look at Connect Biopharma Holdings Ltd ADR’s (CNTB) current performance indicators. Last quarter, stock had a quick ratio of 10.25. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.67 in one year’s time.
Technical Analysis of Connect Biopharma Holdings Ltd ADR (CNTB)
Analysing the last 5-days average volume posted by the [Connect Biopharma Holdings Ltd ADR, CNTB], we can find that recorded value of 0.24 million was better than the volume posted last year of 90364.0. As of the previous 9 days, the stock’s Stochastic %D was 76.99%.
During the past 100 days, Connect Biopharma Holdings Ltd ADR’s (CNTB) raw stochastic average was set at 96.19%, which indicates a significant increase from 93.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1148 in the past 14 days, which was higher than the 0.0831 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8975, while its 200-day Moving Average is $0.9797. Now, the first resistance to watch is $1.6850. This is followed by the second major resistance level at $1.8500. The third major resistance level sits at $2.1400. If the price goes on to break the first support level at $1.2300, it is likely to go to the next support level at $0.9400. Now, if the price goes above the second support level, the third support stands at $0.7750.
Connect Biopharma Holdings Ltd ADR (NASDAQ: CNTB) Key Stats
The company with the Market Capitalisation of 84.13 million has total of 55,561K Shares Outstanding. Its annual sales at the moment are 26,030 K in contrast with the sum of -15,630 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -10,270 K.
